THE GREATER CANNABIS COMPANY, INC. Inactive Instrument
The Greater Cannabis Company, Inc. Stock Other OTC
Equities
GCAN
US3916571033
Internet Services
Financials (USD)
| Sales 2022 | - | Sales 2023 | - | Capitalization | 661K |
|---|---|---|---|---|---|
| Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | - |
| Net Debt 2022 | 233K | Net Debt 2023 | 265K | EV / Sales 2023 | - |
| P/E ratio 2022 |
-0.9
x | P/E ratio 2023 |
-3.45
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.7% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Aitan Zacharin
CEO | Chief Executive Officer | 41 | 14-03-13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Aitan Zacharin
CEO | Chief Executive Officer | 41 | 14-03-13 |
The Greater Cannabis Company, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of cannabinoid therapeutics. The Company conducts medical research, and is pursuing clinical trials, to develop cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. The Company conducts clinical studies on and commercialize the cannabinoid-based therapeutic and concentrate on cannabis related investment and development opportunities through direct equity investments, joint ventures, licensing agreements or acquisitions. Its delivery technologies use a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides needle free, intra-oral systemic drug delivery.
Sector
Internet Services
| 1st Jan change | Capi. | |
|---|---|---|
| +17.51% | 413B | |
| +14.91% | 241B | |
| +9.47% | 140B | |
| +19.18% | 103B | |
| +16.86% | 83.94B | |
| +52.33% | 56.98B | |
| +33.60% | 53.38B | |
| +5.85% | 37.77B | |
| +15.64% | 34.36B |
